The global Coagulation Analyzers/Reagents Market size is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.
The most relevant advancement includes combination
of different assay procedures in single equipment and various commercially
available hemostasis analyzers, which are capable of performing tests such as
Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer,
and Fibrinogen as well as these machines can perform chromogenic and
immunologic assays.
Moreover, these systems may have the capacity of
holding more samples, providing faster results, and increasing the efficiency
of laboratory workflow. The advancements in hemostasis analyzers are as
follows:
- Integration of the system with track line systems and work cells,
which may improve the reliability of analysis in terms of single detection
system and preanalytical check for interfering substances
- Failure pattern sensors, which detect insufficient sample levels and
clots and cap piercing, which enhances safety and sample integrity
- Automatic reflex testing, repeat testing, and redilution
Request
a sample copy or view summary of this report @ http://www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market
Further key findings from the study suggest:
- Clinical laboratory analyzers held over 70.0% of the market share in
2015 and are predicted to sustain its dominance over the forecast period.
- Advantages such as use of whole blood as sample, no pre-analytical
delay and requirement of lesser reagents, further boost growth of Point of
Care analyzers.
- Reagents held the highest market share in 2015. This dominance may
be attributed to increasing usage of hemostasis analyzers coupled with
easy availability of reagents.
- Optical technology based hemostasis analyzers held the largest share
in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast
period.
- The coagulation analyzer market is majorly dominated by the
prothrombin test. The APTT test is estimated to account for the second
largest share in the market in 2015.
- Hospitals are expected to witness lucrative growth over the forecast
period. This can be attributed to high number of hospitals in developing
economies.
- For instance, Mexico has over 4,500 hospitals and out of these 67.0%
hospitals are private and remaining 33.0% hospitals are public hospitals.
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment